메뉴 건너뛰기




Volumn 4, Issue 4, 2003, Pages 241-242

CBP 1011: Colirest™, Hematrol™
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CBP 1011; COLIREST; HEMATROL; INTERLEUKIN 6; MEDROXYPROGESTERONE; STEROID; TUMOR NECROSIS FACTOR;

EID: 0043136563     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200304040-00005     Document Type: Article
Times cited : (2)

References (3)
  • 1
    • 85009044283 scopus 로고    scopus 로고
    • InKine Pharmaceutical Company Inc. InKine Announces U.S. "'Notice of Allowance"' for Colirest-TM Patent. Media Release: 23 Apr Available from URL
    • InKine Pharmaceutical Company Inc. InKine Announces U.S. "'Notice of Allowance"' for Colirest-TM Patent. Media Release: 23 Apr 2003. Available from URL: http://www.inkine.com
    • (2003)
  • 2
    • 85009044157 scopus 로고    scopus 로고
    • InKine announces positive results for Colirest (TM) in patients with ulcerative colitis
    • InKine Pharmaceuticals Company Inc. Media Release: [3 pages], 11 Dec Available from: URL
    • InKine Pharmaceuticals Company Inc. InKine announces positive results for Colirest (TM) in patients with ulcerative colitis. Media Release: [3 pages], 11 Dec 2000. Available from: URL: http://www.inkine.com
    • (2000)
  • 3
    • 85009038617 scopus 로고    scopus 로고
    • InKine Pharmaceutical announces positive results for CBP-1011 in patients with Crohn's disease
    • InKine Pharmaceutical Company. Media Release: [2 pages], 11 Sep Available from URL:
    • InKine Pharmaceutical Company. InKine Pharmaceutical announces positive results for CBP-1011 in patients with Crohn's disease. Media Release: [2 pages], 11 Sep 2000. Available from URL: http://www.inkine.com
    • (2000)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.